Dietary α-linolenic acid increases the platelet count in ApoE-/- mice by reducing clearance

Blood

Volumn 122, Issue 6, 2013, Pages 1026-1033

  Stivala, Simona ^a,b   Reiner, Martin F ^a,b   Lohmann, Christine ^a   Lüscher, Thomas F ^a,c   Matter, Christian M ^a,c   Beer, Juerg H ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Cantonal Hospital Baden   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GLYCOCALICIN; GLYCOPROTEIN IB; INTEGRIN; LINOLENIC ACID; PADGEM PROTEIN; THROMBIN; THROMBOPOIETIN; VON WILLEBRAND FACTOR; ADAM PROTEIN; FIBRINOGEN RECEPTOR; THROMBIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; BONE MARROW; CHOLESTEROL DIET; CONTROLLED STUDY; DIETARY INTAKE; LIVER; MALE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SPLEEN; THROMBOCYTE COUNT; ANIMAL; ANIMAL FOOD; ATHEROSCLEROSIS; C57BL MOUSE; DRUG EFFECT; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

ADAM PROTEINS; ALPHA-LINOLENIC ACID; ANIMAL FEED; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PLATELETS; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P-SELECTIN; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SIGNAL TRANSDUCTION; SPLEEN;

EID: 84886910212     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-484741     Document Type: Article

References (33)

1. Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene. 2002; 21(21):3359-3367.
2. Josefsson EC, White MJ, Dowling MR, Kile BT. Platelet life span and apoptosis. Methods Mol Biol. 2012;788:59-71.
3. Grozovsky R, Hoffmeister KM, Falet H. Novel clearance mechanisms of platelets. Curr Opin Hematol. 2010;17(6):585-589.
4. Hoffmeister KM. The role of lectins and glycans in platelet clearance. J Thromb Haemost. 2011; 9(March Suppl 1):35-43.
5. van der Wal DE, Du VX, Lo KSL, Rasmussen JT, Verhoef S, Akkerman JW. Platelet apoptosis by cold-induced glycoprotein Ibα clustering. J Thromb Haemost. 2010;8(11):2554-2562.
6. Coupland LA, Cromer D, Davenport MP, Parish CR. A novel fluorescent-based assay reveals that thrombopoietin signaling and Bcl-x(l) influence, respectively, platelet and erythrocyte lifespans. Exp Hematol. 2010;38(6):453–461.
7. Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20): 2047-2067.
8. Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376(9740): 540-550.
9. Kromhout D, Yasuda S, Geleijnse JM, Shimokawa H. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? Eur Heart J. 2012;33(4):436-443.
10. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem. 2010;21(9):781-792.
11. Eussen SRBM, Geleijnse JM, Giltay EJ, Rompelberg CJ, Klungel OH, Kromhout D. Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction. Eur Heart J. 2012;33(13): 1582-1588.
12. Guillot N, Caillet E, Laville M, et al. Increasing intakes of the long-chain omega-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J. 2009;23(9):2909-2916.
13. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med. 2011;364(25): 2439-2450.
14. Kromhout D, Giltay EJ, Geleijnse JM; Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363(21):2015-2026.
15. Li D, Sinclair A, Wilson A, et al. Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. Am J Clin Nutr. 1999;69(5): 872-882.
16. Albert CM, Oh K, Whang W, et al. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation. 2005;112(21):3232-3238.
17. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343(8911):1454-1459.
18. Singh RB, Dubnov G, Niaz MA, et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet. 2002; 360(9344):1455-1461.
19. Campos H, Baylin A, Willett WC. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation. 2008;118(4):339-345.
20. Winnik S, Lohmann C, Richter EK, et al. Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation. Eur Heart J. 2011;32(20): 2573-2584.
21. Holy EW, Forestier M, Richter EK, et al. Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation. Arterioscler Thromb Vasc Biol. 2011; 31(8):1772-1780.
22. Stivala S, Lohmann C, Holy EW, Matter CM, Beer JH. Analysis of the mechanisms of increased platelet count induced by dietary α-linolenic acid indicates reduced cleavage of gpib and reduced p38 phosphorylation [abstract]. Blood. 2011;118(21):2198.
23. Jansen AJ, Josefsson EC, Rumjantseva V, et al. Desialylation accelerates platelet clearance after refrigeration and initiates GPibα metalloproteinase-mediated cleavage in mice. Blood. 2012;119(5):1263-1273.
24. Beer JH, Büchi L, Steiner B. Glycocalicin: a new assay—the normal plasma levels and its potential usefulness in selected diseases. Blood. 1994; 83(3):691-702.
25. Dowling MR, Josefsson EC, Henley KJ, Hodgkin PD, Kile BT. Platelet senescence is regulated by an internal timer, not damage inflicted by hits. Blood. 2010;116(10):1776-1778.
26. Barsam SJ, Psaila B, Forestier M, et al. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood. 2011;117(21):5723-5732.
27. Bergmeier W, Piffath CL, Cheng G, et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res. 2004;95(7):677-683.
28. Brill A, Chauhan AK, Canault M, Walsh MT, Bergmeier W, Wagner DD. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res. 2009;84(1):137-144.
29. ORIGIN Trial Investigators, Bosch J, Gerstein HC, et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012; 367(4):309-318.
30. Doenyas-Barak K, Berman S, Abu-Hamad R, et al. N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients’ daytime blood pressure, and improves inflammatory status. Eur J Clin Pharmacol. 2012; 68(8):1139-1146.
31. Pan A, Chen M, Chowdhury R, et al. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012;96(6):1262-1273.
32. Risk and Prevention Study Collaborative Group, Roncaglioni MC, Tombesi M, et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med. 2013;368(19): 1800-1808.
33. Xu P, Derynck R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell. 2010;37(4): 551-566.